Mitochondria, an exciting new target for the treatment of anxiety disorders
One third of patients with anxiety disorders do not respond to currently available anxiolytic treatments. In their latest study, scientists at the Max Planck Institute of Psychiatry in Munich have shown for the first time ...
Dec 16, 2015
0
537